SCHEMBL21481211

SCHEMBL21481211

c1ccc(-c2cc(-c3nc(-c4ccncc4)nc(-c4ccncc4)n3)ccc2-c2cccc(-c3cccc(-c4ccc5ccccc5c4)c3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK9 P45984 4/20 0.46
▸ MAPK10 P53779 4/20 0.46
▸ MAPK8 P45983 2/20 0.46
▸ SIRT2 Q8IXJ6 1/20 0.45
▸ CYP17A1 P05093 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ CYP11B1 P15538 1/20 0.44
▸ CYP11B2 P19099 1/20 0.44
▸ MAPK14 Q16539 5/20 0.43
▸ CSNK1D P48730 4/20 0.43
▸ MAPK11 Q15759 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21481688 1.00 MAPK9 (0.46) MAPK9MAPK10MAPK8SIRT2CYP17A1
SCHEMBL25461122 0.95 CYP1A1 (0.45) MAPK9MAPK10MAPK8SIRT2CYP17A1
SCHEMBL25461004 0.95 MAPK9 (0.44) MAPK9MAPK10MAPK8SIRT2CYP17A1
SCHEMBL25871434 0.94 MAPK9 (0.48) MAPK9MAPK10MAPK8SIRT2CYP17A1
SCHEMBL21481425 0.93 MAPK9 (0.47) MAPK9MAPK10MAPK8SIRT2CYP17A1
SCHEMBL21481680 0.93 MAPK9 (0.47) MAPK9MAPK10MAPK8SIRT2CYP17A1
SCHEMBL25460479 0.93 MAPT (0.48) MAPK14MAPK11ALDH1A1SMN1; SMN2MAPT
SCHEMBL21481685 0.93 MEN1 (0.46) SIRT2CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL21481213 0.93 MEN1 (0.46) SIRT2CYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL26592319 0.93 MEN1 (0.46) SIRT2CYP17A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE PIEZO1, OR10J3, OR51E2 MAPK9 1994/4885MAPK10 2907/4885MAPK8 2941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback